semax selank bpc-157 neuroprotection anesthesia or surgery recovery SEMAX/SELANK Semax + Selank Bundle —

The following is a summary of documented tissue systems from peer-reviewed literature: This cross-tissue activity profile is directly attributable to the fact that its primary mechanisms VEGFR2-driven angiogenesis and NO system modulation are not tissue-specific

PubMed: 11700589 AOD 9604 Effects on Visceral Adiposity, Metabolic Syndrome, and Insulin Sensitivity in Obese Mice animal Shen Y, Liu B, Duong T, et al

Doses as low as 10100 g/kg have been reported to significantly improve tissue regeneration, reduce inflammation, and counteract NSAID-induced damage

Oral presentations during the open public hearing require a separate request submitted to the FDA in advance